7 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
A1C and eAG ~ ... Diabetes #T2D #DM2 ... #Table #PrimaryCare ... #Endocrinology ... #BloodGlucose #A1C
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
#SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #Management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... #medications #table ... #comparison #management ... #endocrinology ... #dm2
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
summarizes the A1C ... pharmacotherapy #table ... #comparison #management ... medications #diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
has a smaller A1c ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
fundamental to the management ... A1C% measurement ... guidelines #management ... #endocrinology ... decisionaid #treatment #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Insulin dependent DM ... event, follow ACC ... Stable patients ... indication of AC ... medical and surgical management